Case Study

A Year In, 22% Behind. Back on Track in Under 90 Days. 

A mid-sized biopharma brought ProofPilot a Phase II solid-tumor oncology trial running 22% behind plan at month 14 of a 24-month window. The Enrollment Optimizer diagnosed cohort drift, triaged site performance, and modelled a recovery path that the sponsor executed in one steering cycle.

EO Case Study Graphics

📉 ProofPilot identified the root causes behind declining enrollment, rising screen-fail rates, and underperforming countries.

🔍 Live trial data was used to model recovery scenarios and determine the fastest path back to target.

📈 The sponsor increased projected completion odds from 48% to 89%, improved screening performance, and restored enrollment velocity within 12 weeks.

iStock
A-LIGN_SOC-2 Logo
image 10
image 8
attachment (3) 1
image 7
Group 3a02